Key Details
Annual ROE
-77.12%Beta
-Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
Nov 10, 2021Recent annual earnings:
Mar 17, 2021Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Aug 17, 2023Analyst ratings
Recent major analysts updates
16 Aug '22 HC Wainwright & Co.
Buy25 Nov '20 H.C. Wainwright
Buy17 Nov '20 HC Wainwright & Co.
Neutral17 Nov '20 H.C. Wainwright
NeutralScreeners with DFFN included
No data
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Diffusion Pharmaceuticals doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Similar stocks
FAQ
- What is the primary business of Diffusion Pharmaceuticals?
- What is the ticker symbol for Diffusion Pharmaceuticals?
- Does Diffusion Pharmaceuticals pay dividends?
- What sector is Diffusion Pharmaceuticals in?
- What industry is Diffusion Pharmaceuticals in?
- What country is Diffusion Pharmaceuticals based in?
- When did Diffusion Pharmaceuticals go public?
- Is Diffusion Pharmaceuticals in the S&P 500?
- Is Diffusion Pharmaceuticals in the NASDAQ 100?
- Is Diffusion Pharmaceuticals in the Dow Jones?
- When was Diffusion Pharmaceuticals's last earnings report?
- When does Diffusion Pharmaceuticals report earnings?
- Should I buy Diffusion Pharmaceuticals stock now?
What is the primary business of Diffusion Pharmaceuticals?
Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. The company was founded in 2001 and is based in Charlottesville, Virginia.
What is the ticker symbol for Diffusion Pharmaceuticals?
The ticker symbol for Diffusion Pharmaceuticals is NASDAQ:DFFN
Does Diffusion Pharmaceuticals pay dividends?
No, Diffusion Pharmaceuticals does not pay dividends
What sector is Diffusion Pharmaceuticals in?
Diffusion Pharmaceuticals is in the Healthcare sector
What industry is Diffusion Pharmaceuticals in?
Diffusion Pharmaceuticals is in the Biotechnology industry
What country is Diffusion Pharmaceuticals based in?
Diffusion Pharmaceuticals is headquartered in United States
When did Diffusion Pharmaceuticals go public?
Diffusion Pharmaceuticals's initial public offering (IPO) was on 23 May 2008
Is Diffusion Pharmaceuticals in the S&P 500?
No, Diffusion Pharmaceuticals is not included in the S&P 500 index
Is Diffusion Pharmaceuticals in the NASDAQ 100?
No, Diffusion Pharmaceuticals is not included in the NASDAQ 100 index
Is Diffusion Pharmaceuticals in the Dow Jones?
No, Diffusion Pharmaceuticals is not included in the Dow Jones index
When was Diffusion Pharmaceuticals's last earnings report?
Diffusion Pharmaceuticals's most recent earnings report was on 10 November 2021
When does Diffusion Pharmaceuticals report earnings?
The date for Diffusion Pharmaceuticals's next earnings report has not been announced yet
Should I buy Diffusion Pharmaceuticals stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions